CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Early Experiences with Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Failed Target Therapy
Jong Hoon Lee, Minyong Kang, Jae Hoon Chung, Hyun Hwan Sung, Hwang Gyun Jeon, Byung Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park, Binnari Kim, Ghee Young Kwon, Seong Il Seo
Korean J Urol Oncol. 2019;17(2):96-102.   Published online 2019 August 30    DOI: https://doi.org/10.22465/kjuo.2019.17.2.96

Excel Download

Early Experiences with Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Failed Target Therapy
The Korean Journal of Urological Oncology. 2019;17(2):96-102   Crossref logo
Link1 Link2 Link3

Forthcoming Drugs for Metastatic Renal Cell Carcinoma Therapy
Renal Cell Carcinoma. 2017;333-349   Crossref logo
Link1

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
Scientific Reports. 2017;7(1):   Crossref logo
Link1 Link2 Link3

Changes of TCR repertoire in metastatic renal cell carcinoma and metastatic melanoma patients treated with nivolumab
Annals of Oncology. 2019;30:v514-v515   Crossref logo
Link1 Link2 Link3

Nivolumab in metastatic renal cell carcinoma
Nature Reviews Urology. 2014;12(2):63-63   Crossref logo
Link1 Link2 Link3

Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?
Journal of Oncology Pharmacy Practice. 2019;26(4):1000-1004   Crossref logo
Link1 Link2 Link3

Renal allograft rejection after treatment with nivolumab in patients with metastatic renal cell carcinoma
International Cancer Conference Journal. 2021;10(2):116-118   Crossref logo
Link1 Link2 Link3

TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma
Annals of Oncology. 2021;32(1):97-102   Crossref logo
Link1 Link2

Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy
Japanese Journal of Clinical Oncology. 2021;51(12):1744-1750   Crossref logo
Link1 Link2

Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma
Japanese Journal of Clinical Oncology. 2018;48(9):860-863   Crossref logo
Link1